SciBase Holding AB (publ), a medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and assess skin barrier and inflammation. It has a collaboration with Vrije Universiteit Brussel University hospitals for early detection of atopic diseases in infants through the use of electrical impedance spectroscopy technology. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden
Metrics to compare | SCIB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCIBPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.1x | −3.6x | −0.7x | |
PEG Ratio | −0.06 | −0.01 | 0.00 | |
Price/Book | 1.9x | 2.8x | 2.6x | |
Price / LTM Sales | 2.6x | 3.9x | 3.2x | |
Upside (Analyst Target) | 370.6% | 85.4% | 44.1% | |
Fair Value Upside | Unlock | 20.1% | 8.2% | Unlock |